دورية أكاديمية
Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
| العنوان: | Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke |
|---|---|
| المؤلفون: | Patzwaldt, Kristin, Berezhnoy, Georgy, Ionescu, Tudor, Schramm, Linda, Wang, Yi, Owczorz, Miriam, Calderón, Eduardo, Poli, Sven, Serna Higuita, Lina M, Gonzalez-Menendez, Irene, Quintanilla-Martinez, Leticia, Herfert, Kristina, Pichler, Bernd, Trautwein, Christoph, Castaneda-Vega, Salvador |
| المساهمون: | Clinician-Scientist Programme of the Faculty of Medicine, University of Tuebingen, Werner Siemens Stiftung, Bruker Biospin |
| المصدر: | Brain Communications ; volume 5, issue 2 ; ISSN 2632-1297 |
| بيانات النشر: | Oxford University Press (OUP) |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Neurology, Cellular and Molecular Neuroscience, Biological Psychiatry, Psychiatry and Mental health |
| الوصف: | Ambroxol is a well-known mucolytic expectorant, which has gained much attention in amyotrophic lateral sclerosis, Parkinson’s and Gaucher’s disease. A specific focus has been placed on ambroxol’s glucocerebrosidase-stimulating activity, on grounds that the point mutation of the gba1 gene, which codes for this enzyme, is a risk factor for developing Parkinson’s disease. However, ambroxol has been attributed other characteristics, such as the potent inhibition of sodium channels, modification of calcium homeostasis, anti-inflammatory effects and modifications of oxygen radical scavengers. We hypothesized that ambroxol could have a direct impact on neuronal rescue if administered directly after ischaemic stroke induction. We longitudinally evaluated 53 rats using magnetic resonance imaging to examine stroke volume, oedema, white matter integrity, resting state functional MRI and behaviour for 1 month after ischemic stroke onset. For closer mechanistic insights, we evaluated tissue metabolomics of different brain regions in a subgroup of animals using ex vivo nuclear magnetic resonance spectroscopy. Ambroxol-treated animals presented reduced stroke volumes, reduced cytotoxic oedema, reduced white matter degeneration, reduced necrosis, improved behavioural outcomes and complex changes in functional brain connectivity. Nuclear magnetic resonance spectroscopy tissue metabolomic data at 24 h post-stroke proposes several metabolites that are capable of minimizing post-ischaemic damage and that presented prominent shifts during ambroxol treatment in comparison to controls. Taking everything together, we propose that ambroxol catalyzes recovery in energy metabolism, cellular homeostasis, membrane repair mechanisms and redox balance. One week of ambroxol administration following stroke onset reduced ischaemic stroke severity and improved functional outcome in the subacute phase followed by reduced necrosis in the chronic stroke phase. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/braincomms/fcad099 |
| DOI: | 10.1093/braincomms/fcad099/49684272/fcad099.pdf |
| الإتاحة: | https://doi.org/10.1093/braincomms/fcad099Test https://academic.oup.com/braincomms/article-pdf/5/2/fcad099/49855493/fcad099.pdfTest |
| حقوق: | https://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.ED3AFB27 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/braincomms/fcad099 |
|---|